Showing results (81-90 of 313) with videos related to
Sort By:
Pageof 32
Cerebrovascular Diseases (Basel, Switzerland)|August 5, 2006
Patterns of cerebral perfusion in patients with asymptomatic internal carotid artery diseaseClaudia Chaves, Kinan Hreib, Gregory Allam, et al.Frontiers in Neurology|November 5, 2019
Vertebral Artery Compression SyndromeQi Li, Peng Xie, Wen-Song Yang, et al.Frontiers in Neurology|November 23, 2017
Computed Tomography Perfusion Alberta Stroke Program Early Computed Tomography Score Is Associated with Hemorrhagic Transformation after Acute Cardioembolic StrokeLan Liu, Bo Wu, Jinglong Zhao, et al.Annual Review of Medicine|January 18, 2006
Use of stents to treat extracranial cerebrovascular diseasePhilip M Meyers, H Christian Schumacher, Randall T Higashida, et al.Cerebrovascular Diseases (Basel, Switzerland)|June 25, 2005
Neurotransplantation of fetal porcine cells in patients with basal ganglia infarcts: a preliminary safety and feasibility studySean I Savitz, Jonathan Dinsmore, Julian Wu, et al.Annals of Neurology|September 3, 2002
Cell transplantation for strokeSean I Savitz, Daniel M Rosenbaum, Jonathan H Dinsmore, et al.Archives of Neurology|January 21, 2004
Safety of latest-generation self-expanding stents in patients with NASCET-ineligible severe symptomatic extracranial internal carotid artery stenosisItalo Linfante, Joshua A Hirsch, Magdy Selim, et al.Neurorx : the Journal of the American Society for Experimental Neurotherapeutics|February 18, 2005
Cell therapy for strokeSean I Savitz, Jonathan H Dinsmore, Lawrence R Wechsler, et al.European Neurology|May 14, 2016
Susceptibility Vessel Sign in Isolated Brainstem Infarction with Large Artery OcclusionMingrui Song, Qimin Hu, Yan Wang, et al.Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|June 26, 2013
Cost-effectiveness of trabectedin plus pegylated liposomal doxorubicin for the treatment of women with relapsed platinum-sensitive ovarian cancer in the UK: analysis based on the final survival data of the OVA-301 trialMark Fisher, Martin GorePageof 32